Instrument Inactif

Autres langues Aastrom Biosciences Inc Nasdaq

Actions

US00253U3059

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

16/09	Transcript : Vericel Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 02:35 PM
31/07	Vericel Corporation : Truist Securities optimiste sur le dossier	ZM

Autres langues

08/09	Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
30/07	Vericel Corporation authorizes a Buyback Plan.
30/07	Vericel Corporation announces an Equity Buyback for $200 million worth of its shares.
30/07	Vericel Swings to Q2 Net Income, Revenue Rises; Full-Year 2026 Revenue Guidance Raised
30/07	Vericel Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
30/07	Vericel Corporation Raises Revenue Guidance for the Year 2026
30/07	(VCEL) Vericel Expects Full Year 2026 Revenue Range $330M - $340M, vs. FactSet Est of $332.2M
30/07	Earnings Flash (VCEL) Vericel Posts Q2 EPS $0.04, vs. FactSet Est. of $0.03 Loss
30/07	Earnings Flash (VCEL) Vericel Corporation Reports Q2 Revenue $77.5M, vs. FactSet Est of $72.7M
30/07	Vericel : Q2 2026 Earnings Call Presentation
30/07	Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
16/07	Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
09/06	Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
22/05	The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
07/05	Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
07/05	Vericel Shares Rise After Q1 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Lifted
07/05	(VCEL) Vericel Expects 2026 Total Revenue Range $326M to $336M, vs. FactSet Est of $323.4M
07/05	Earnings Flash (VCEL) Vericel Posts Q1 Net Loss $0.12 a Share, vs. FactSet Est of $0.15 Loss
07/05	Earnings Flash (VCEL) Vericel Corporation Reports Q1 Revenue $68.4M, vs. FactSet Est of $63.7M
07/05	Vericel : Q1 2026 Earnings Call Presentation
07/05	Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
07/05	Vericel Corporation Raised Revenue Guidance for the Year 2026
23/04	Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
02/04	Vericel Corporation Receives BARDA Contract Valued At Up To USD 197 Million For Procurement And Advanced Development Of NexoBrid
02/04	Vericel Wins Ten-Year Contract Valued at up to $197 Million for Procurement, Development of NexoBrid